NASDAQ: TRIThomson Reuters Corp Stock
$181.66-0.37 (-0.2%)
Updated Apr 25, 2025
TRI Price
$181.66
Fair Value Price
N/A
Market Cap
$81.75B
52 Week Low
$149.85
52 Week High
$184.11
P/E
37.15x
P/B
6.81x
P/S
9.96x
PEG
N/A
Dividend Yield
1.22%
Revenue
$7.26B
Earnings
$2.20B
Gross Margin
100%
Operating Margin
30.39%
Profit Margin
30.4%
Debt to Equity
0.54
Operating Cash Flow
$2B
Beta
0.63
Next Earnings
Apr 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
TRI Overview
Thomson Reuters Corporation provides business information services in the U.S. and internationally. The Legal Professionals segment offers legal research and integrated legal workflow solutions that combine content, tools, and analytics to law firms and governments. The Reuters News segment provides business, financial, and international news to media organizations. The company was founded in 1851 and is headquartered in Toronto, Canada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TRI's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Business Service
Industry Rating
B
TRI
Ranked#27 of 32
Ranked#27 of 32
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.11 | A | |
| $5.20 | B | |
| $22.33 | B |
Be the first to know about important TRI news, forecast changes, insider trades & much more!
TRI News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TRI scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TRI is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TRI is poor value based on its earnings relative to its share price (37.15x), compared to the US market average (29.65x)
P/E vs Market Valuation
TRI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more TRI due diligence checks available for Premium users.
Valuation
TRI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
37.15x
Industry
38.06x
Market
29.65x
TRI is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TRI is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
TRI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.81x
Industry
5.16x
TRI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TRI's financial health
Profit margin
Revenue
$1.9B
Net Income
$587.0M
Profit Margin
30.7%
TRI's Earnings (EBIT) of $2.21B... subscribe to Premium to read more.
Interest Coverage Financials
TRI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$18.4B
Liabilities
$6.4B
Debt to equity
0.54
TRI's short-term assets ($3.49B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TRI's short-term assets ($3.49B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TRI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TRI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$564.0M
Investing
-$69.0M
Financing
-$252.0M
TRI's operating cash flow ($2.46B)... subscribe to Premium to read more.
Debt Coverage Financials
TRI vs Specialty Business Service Stocks
Thomson Reuters Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.